Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q117256516 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241221010641.0 | ||
| 008 | 241221nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q117256516 | ||
| 035 | ‡a (OCoLC)Q117256516 | ||
| 100 | 0 | ‡a Katherine I Lin ‡c researcher ‡9 en | |
| 670 | ‡a Author's p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapy | ||
| 670 | ‡a Author's Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens | ||
| 919 | ‡a relevanceoftheimmunoglobulinvhsomaticmutationstatusinpatientswithchroniclymphocyticleukemiatreatedwithfludarabinecyclophosphamideandrituximabfcrorrelatedchemoimmunotherapyregimens ‡A Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens ‡9 1 | ||
| 919 | ‡a p53expressionbyimmunohistochemistryisanimportantdeterminantofsurvivalinpatientswithchroniclymphocyticleukemiareceivingfrontlinechemoimmunotherapy ‡A p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapy ‡9 1 | ||
| 996 | ‡2 LC|no2014152660 | ||
| 996 | ‡2 NLA|000036664325 | ||
| 996 | ‡2 CYT|AC000614038 | ||
| 996 | ‡2 LC|n 2019016520 | ||
| 996 | ‡2 NLA|000036719655 | ||
| 996 | ‡2 LC|nr2004001820 | ||
| 996 | ‡2 ISNI|0000000383612311 | ||
| 996 | ‡2 LC|nr 93044868 | ||
| 996 | ‡2 LC|n 2020043627 | ||
| 996 | ‡2 DNB|1203405669 | ||
| 996 | ‡2 BIBSYS|90238764 | ||
| 996 | ‡2 LC|n 99024696 | ||
| 996 | ‡2 NTA|412459264 | ||
| 996 | ‡2 SUDOC|233614842 | ||
| 996 | ‡2 LC|n 92047872 | ||
| 996 | ‡2 BNF|18090684 | ||
| 996 | ‡2 NII|DA07956988 | ||
| 996 | ‡2 NSK|000233663 | ||
| 996 | ‡2 NII|DA01976428 | ||
| 996 | ‡2 PLWABN|9810579039805606 | ||
| 996 | ‡2 DNB|130631092X | ||
| 996 | ‡2 NLA|000036630342 | ||
| 996 | ‡2 SUDOC|241612772 | ||
| 996 | ‡2 LC|n 82270409 | ||
| 996 | ‡2 NLA|000036646043 | ||
| 996 | ‡2 LC|no2023066364 | ||
| 996 | ‡2 ISNI|0000000064263556 | ||
| 996 | ‡2 ISNI|0000000512310951 | ||
| 996 | ‡2 NLA|000036691181 | ||
| 996 | ‡2 NLA|000036674950 | ||
| 996 | ‡2 ISNI|0000000432657445 | ||
| 996 | ‡2 RERO|A013372964 | ||
| 996 | ‡2 BIBSYS|90247948 | ||
| 996 | ‡2 ISNI|0000000063617041 | ||
| 996 | ‡2 NLA|000036616902 | ||
| 996 | ‡2 NLA|000036682996 | ||
| 996 | ‡2 ISNI|0000000063531950 | ||
| 996 | ‡2 BNF|13548955 | ||
| 996 | ‡2 NII|DA19444203 | ||
| 996 | ‡2 RERO|A003522039 | ||
| 996 | ‡2 ISNI|0000000064042980 | ||
| 996 | ‡2 SUDOC|050817124 | ||
| 996 | ‡2 ISNI|0000000064051844 | ||
| 996 | ‡2 BIBSYS|90742491 | ||
| 996 | ‡2 ISNI|0000000063505058 | ||
| 996 | ‡2 ISNI|0000000063736390 | ||
| 996 | ‡2 NSK|000504984 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
